SCHEMBL1928258

SCHEMBL1928258

COC1CCCCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13480296 1.00
SCHEMBL12306213 1.00
SCHEMBL12306201 1.00
SCHEMBL768237 1.00
SCHEMBL13480297 1.00
SCHEMBL23437396 1.00
SCHEMBL2632534 1.00
SCHEMBL16378463 1.00
SCHEMBL13190305 0.94
SCHEMBL18611201 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12044969-B2 Resist underlayer film-forming composition NISSAN CHEMICAL CORPORATION (JP) 2024-07-23 US disclosed
US-12044968-B2 Protective film-forming composition having acetal structure and amide structure NISSAN CHEMICAL CORPORATION (JP) 2024-07-23 US disclosed
WO-2024137607-A1 THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2024-06-27 WO disclosed
WO-2023239727-A1 LATS INHIBITORS AND USES THEREOF THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2023-12-14 WO disclosed
US-20230360821-A1 SILANE FUNCTIONAL STABILIZERS FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE AMINDON INC. 2023-11-09 US disclosed
US-20230360821-A1 SILANE FUNCTIONAL STABILIZERS FOR EXTENDING LONG-TERM ELECTRICAL POWER CABLE PERFORMANCE AMINDON INC. 2023-11-09 US disclosed
US-20230350299-A1 STEP SUBSTRATE COATING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2023-11-02 US disclosed
US-20230317527-A1 WAFER TREATMENT METHOD NISSAN CHEMICAL CORPORATION (JP) 2023-10-05 US disclosed
US-11768436-B2 Protective film forming composition having a diol structure NISSAN CHEMICAL CORPORATION (JP) 2023-09-26 US disclosed
EP-3582275-B1 PHOTOELECTRIC CONVERSION ELEMENT, OPTICAL AREA SENSOR USING SAME, IMAGING ELEMENT, AND IMAGING DEVICE CANON KK (JP) 2023-09-06 EP disclosed
US-7166614-B2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity MERCK & CO., INC. (US) 2007-01-23 US disclosed
US-7166614-B2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity MERCK & CO., INC. (US) 2007-01-23 US disclosed
US-7163997-B2 Polyether derivative and process for producing the same FUJI PHOTO FILM CO., LTD. (JP) 2007-01-16 US disclosed
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 WO disclosed
WO-2003062265-A2 NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORPORATION (US) 2003-07-31 WO disclosed
WO-2002014253-A1 CYCLOHEXYL ETHERS AS FRAGRANCE COMPOUNDS QUEST INTERNATIONAL B.V. (NL) 2002-02-21 WO disclosed
EP-0562343-B1 Process for the preparation of esters of beta-hydroxycarboxylic acids BASF AG (DE) 1995-11-15 EP disclosed
US-5294731-A Preparation of β-hydroxycarboxylates BASF AKTIENGESELLSCHAFT (DE) 1994-03-15 US disclosed
EP-0562343-A1 Process for the preparation of esters of beta-hydroxycarboxylic acids BASF Aktiengesellschaft (DE) 1993-09-29 EP disclosed
US-4497815-A 1-(N-Substituted carbamoyl)-5-fluorouracil derivatives and the carcinostatic agents containing same as active ingredients Ozaki, Shoichiro (JP) 1985-02-05 US disclosed